Product Information
3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol is a compound that has been shown to lower blood glucose levels in animal models and has potent oral efficacy, as well as agonistic activity at the GLP-1 receptor. It is currently in phase II clinical trials for the treatment of type 2 diabetes. 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol is an orally active compound that lowers glucose levels by stimulating insulin secretion and enhancing insulin sensitivity in liver cells. It has been shown to have a conformationally restricted agonist activity at the GLP-1 receptor, which may be due to its structural similarity to octane, a ligand for this receptor
Chemical properties
Technical inquiry about: 3D-WZB18779 3-Oxa-7-azabicyclo[3.3.1]nonan-9-ol
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.